Literature DB >> 27258917

Outcomes From an Enhanced Recovery Program for Laparoscopic Gastric Surgery.

Nathalie Wong-Chong1, Henrik Kehlet, Teodor P Grantcharov.   

Abstract

PURPOSE: To examine the outcomes from an enhanced recovery after surgery (ERAS) program for laparoscopic gastric surgery.
MATERIALS AND METHODS: This was a prospective study of patients undergoing elective laparoscopic gastric resection in an ERAS protocol at a single institution between 2008 and 2012. Outcomes included the length of hospital stay, intraoperative and postoperative complications, the readmission rate, the reoperation rate, and the 30-day mortality.
RESULTS: Of the 86 patients, 60 underwent partial gastrectomy and 26 underwent total gastrectomy. Median lymph nodes sampled was 15 (range, 9 to 47). The median length of hospital stay was 4 (range, 1 to 44) days. The conversion rate to open surgery was 11.6%. Four patients (4.7%) had an anastomotic leak. Three patients had postoperative bleeding (4.7%). About 4.7% (n=4) of the patients required readmission and 8.1% required reoperation (n=7). The 30-day mortality rate was 2.3% (n=2) due to complications from anastomotic leak.
CONCLUSIONS: Laparoscopic gastrectomy within an ERAS protocol results in a short hospital stay with an acceptable morbidity and mortality rate.

Entities:  

Mesh:

Year:  2016        PMID: 27258917     DOI: 10.1097/SLE.0000000000000277

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

1.  Intraoperative Nefopam Reduces Acute Postoperative Pain after Laparoscopic Gastrectomy: a Prospective, Randomized Study.

Authors:  Hyo-Seok Na; Ah-Young Oh; Jung-Hee Ryu; Bon-Wook Koo; Sun-Woo Nam; Jihoon Jo; Jae-Hee Park
Journal:  J Gastrointest Surg       Date:  2018-01-26       Impact factor: 3.452

2.  Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.

Authors:  Noriyuki Hirahara; Yoshitsugu Tajima; Yusuke Fujii; Shunsuke Kaji; Tetsu Yamamoto; Ryoji Hyakudomi; Takahito Taniura; Yasunari Kawabata
Journal:  BMC Cancer       Date:  2018-03-13       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.